Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
about
Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantumAntibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.Escherichia coli cytotoxic necrotizing factor 1 (CNF1): toxin biology, in vivo applications and therapeutic potential.The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.
P2860
Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Intranasal immunization with t ...... mice against lethal challenge.
@en
Intranasal immunization with t ...... mice against lethal challenge.
@nl
type
label
Intranasal immunization with t ...... mice against lethal challenge.
@en
Intranasal immunization with t ...... mice against lethal challenge.
@nl
prefLabel
Intranasal immunization with t ...... mice against lethal challenge.
@en
Intranasal immunization with t ...... mice against lethal challenge.
@nl
P1433
P1476
Intranasal immunization with t ...... mice against lethal challenge.
@en
P2093
Gilles Flatau
P304
P356
10.1016/J.VACCINE.2007.10.024
P407
P577
2007-11-01T00:00:00Z